Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study
- 19 April 2005
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet Oncology
- Vol. 6 (5), 279-286
- https://doi.org/10.1016/s1470-2045(05)70102-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Systemic Therapy for Colorectal CancerThe New England Journal of Medicine, 2005
- Combined Epidermal Growth Factor Receptor Targeting with the Tyrosine Kinase Inhibitor Gefitinib (ZD1839) and the Monoclonal Antibody Cetuximab (IMC-C225)Clinical Cancer Research, 2004
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences of the United States of America, 2004
- Cancer genes and the pathways they controlNature Medicine, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibThe New England Journal of Medicine, 2004
- Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor ReceptorJournal of Clinical Oncology, 2004
- Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferonGut, 2004
- Mutational Analysis of the Tyrosine Kinome in Colorectal CancersScience, 2003
- RAF/RAS oncogenes and mismatch-repair statusNature, 2002